Subscribe
shutterstock_436917634_eqroy
EQroy / Shutterstock.com
20 October 2020BiotechnologyMuireann Bolger

WTO fails to strike deal to waive COVID-19 IP

Talks on a landmark proposal to waive IP rights for vaccines and treatments related to COVID-19 have stalled, following the failure of the World Trade Organisation (WTO) to conclude an agreement.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
WTO 'expected to announce' 17-year drug patent waiver for LDCs
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Big Pharma
South Africa, India urge WTO to waive IP for COVID-19 treatments
8 October 2020   South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
WTO 'expected to announce' 17-year drug patent waiver for LDCs
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Big Pharma
South Africa, India urge WTO to waive IP for COVID-19 treatments
8 October 2020   South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.

More on this story

Big Pharma
WTO 'expected to announce' 17-year drug patent waiver for LDCs
4 November 2015   The World Trade Organization is expected to announce a 17-year extension to an agreement that exempts the world’s Least Developed Countries from a duty to grant patents covering pharmaceutical drugs, an activist group has claimed.
Big Pharma
South Africa, India urge WTO to waive IP for COVID-19 treatments
8 October 2020   South Africa and India have asked the World Trade Organization to cede some stipulations governing IP so that treatments to combat COVID-19 can become more widely available, particularly in low-income countries.
Africa
WTO declines to waive TRIPS provisions for COVID-19 drugs
25 January 2021   Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner